These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28634046)

  • 1. Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells.
    Lee YK; Park UH; Kim EJ; Hwang JT; Jeong JC; Um SJ
    Cancer Lett; 2017 Sep; 403():144-151. PubMed ID: 28634046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer.
    Jia N; Wang J; Li Q; Tao X; Chang K; Hua K; Yu Y; Wong KK; Feng W
    Oncotarget; 2016 Dec; 7(51):84785-84797. PubMed ID: 27764784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
    Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
    Hum Pathol; 2017 Feb; 60():137-146. PubMed ID: 27825810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
    Mori T; Kim J; Yamano T; Takeuchi H; Huang S; Umetani N; Koyanagi K; Hoon DS
    Cancer Res; 2005 Mar; 65(5):1800-7. PubMed ID: 15753377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies.
    Schenk T; Stengel S; Goellner S; Steinbach D; Saluz HP
    Genes Chromosomes Cancer; 2007 Sep; 46(9):796-804. PubMed ID: 17534929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.
    Field MG; Durante MA; Decatur CL; Tarlan B; Oelschlager KM; Stone JF; Kuznetsov J; Bowcock AM; Kurtenbach S; Harbour JW
    Oncotarget; 2016 Sep; 7(37):59209-59219. PubMed ID: 27486988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
    Sigalotti L; Fratta E; Coral S; Tanzarella S; Danielli R; Colizzi F; Fonsatti E; Traversari C; Altomonte M; Maio M
    Cancer Res; 2004 Dec; 64(24):9167-71. PubMed ID: 15604288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: effect of 5-AZA treatment.
    Gutierrez-Cosío S; de la Rica L; Ballestar E; Santamaría C; Sánchez-Abarca LI; Caballero-Velazquez T; Blanco B; Calderón C; Herrero-Sánchez C; Carrancio S; Ciudad L; Cañizo C; San Miguel JF; Pérez-Simón JA
    Leuk Res; 2012 Jul; 36(7):895-9. PubMed ID: 22503131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma.
    Mithani SK; Smith IM; Califano JA
    Melanoma Res; 2011 Aug; 21(4):298-307. PubMed ID: 21606880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor antigen PRAME is a potential therapeutic target of p53 activation in melanoma cells.
    Lee YK; Heo HH; Kim N; Park UH; Youn H; Moon EY; Kim EJ; Um SJ
    BMB Rep; 2024 Jun; 57(6):299-304. PubMed ID: 38835116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells.
    Luo W; Wang X; Kageshita T; Wakasugi S; Karpf AR; Ferrone S
    Oncogene; 2006 May; 25(20):2873-84. PubMed ID: 16407841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients.
    De Carvalho DD; Binato R; Pereira WO; Leroy JM; Colassanti MD; Proto-Siqueira R; Bueno-Da-Silva AE; Zago MA; Zanichelli MA; Abdelhay E; Castro FA; Jacysyn JF; Amarante-Mendes GP
    Oncogene; 2011 Jan; 30(2):223-33. PubMed ID: 20838376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.
    Jayachandran A; Lo PH; Chueh AC; Prithviraj P; Molania R; Davalos-Salas M; Anaka M; Walkiewicz M; Cebon J; Behren A
    BMC Cancer; 2016 Feb; 16():134. PubMed ID: 26907172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
    Gallagher WM; Bergin OE; Rafferty M; Kelly ZD; Nolan IM; Fox EJ; Culhane AC; McArdle L; Fraga MF; Hughes L; Currid CA; O'Mahony F; Byrne A; Murphy AA; Moss C; McDonnell S; Stallings RL; Plumb JA; Esteller M; Brown R; Dervan PA; Easty DJ
    Carcinogenesis; 2005 Nov; 26(11):1856-67. PubMed ID: 15958521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia.
    Ortmann CA; Eisele L; Nückel H; Klein-Hitpass L; Führer A; Dührsen U; Zeschnigk M
    Ann Hematol; 2008 Oct; 87(10):809-18. PubMed ID: 18587578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of SMAD4 by MZF1 inhibits migration of human gastric cancer cells.
    Lee JH; Kim SS; Lee HS; Hong S; Rajasekaran N; Wang LH; Choi JS; Shin YK
    Int J Oncol; 2017 Jan; 50(1):272-282. PubMed ID: 27922669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of BORIS in melanoma: lack of association with MAGE-A1 activation.
    Kholmanskikh O; Loriot A; Brasseur F; De Plaen E; De Smet C
    Int J Cancer; 2008 Feb; 122(4):777-84. PubMed ID: 17957795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MZF1 possesses a repressively regulatory function in ERCC1 expression.
    Yan QW; Reed E; Zhong XS; Thornton K; Guo Y; Yu JJ
    Biochem Pharmacol; 2006 Mar; 71(6):761-71. PubMed ID: 16426580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription Factor Myeloid Zinc-Finger 1 Suppresses Human Gastric Carcinogenesis by Interacting with Metallothionein 2A.
    Lin S; Wang X; Pan Y; Tian R; Lin B; Jiang G; Chen K; He Y; Zhang L; Zhai W; Jin P; Yang L; Li G; Wu Y; Hu J; Gong W; Chang Z; Sheng JQ; Lu Y; Wang JM; Huang J
    Clin Cancer Res; 2019 Feb; 25(3):1050-1062. PubMed ID: 30301827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.